ERS International Congress, Milan 2017

---

Monitoring asthma control

Poster Discussion
Chairs: A. Bikov (Budapest, Hungary), F. Garcia-Cosio Piqueras (Palma de Mallorca, Spain), J. Lopez-Campos Bodineau (Sevilla, Spain)

A study to assess airway remodelling and the utility of low dose CT scoring to evaluate the asthmatic airway. E. Hunt (Cork, Ireland)
An 12-week, Randomised, Parallel-group, Phase III Study comparing the Efficacy of Once-daily Formoterol/Budesonide Turbuhaler 4.5/160 µg and Twice-daily Budesonide Swinghaler 200 µg During Step-down in Well Controlled Asthma N. Nakwan (Songkhla, Thailand)
Time to move away from peak flows in severe asthma? A symptom based score that predicts exacerbations. D. Neville (Portsmouth, United Kingdom)
Exhaled nitric oxide and blood eosinophilia: biomarkers of different adult asthma phenotypes H. Coumou (Amsterdam, Netherlands)
An improved bronchial provocation test with dry powder adenosine instead of nebulised adenosine monophosphate (AMP) A. Lexmond (Groningen, Netherlands)
Benefit of inhaled corticosteroids (ICS) in asthmatic patients with bronchial hyperresponsiveness (BHR) to mannitol and low fractional exhaled nitric oxide (FeNO) levels C. Lake (Camperdown, NSW, Australia)
Point-of-care blood eosinophils count in a severe asthma clinic setting E. Heffler (Torino, To, Italy)
Factors associated with poor asthma control in the year prior to students' first year at university H. Burhan (Liverpool, United Kingdom)
Concordance between Asthma Control Test and the revised GINA criteria of asthma control K. Schultz (Bad Reichenhall, Germany)
Predictors of response to therapy with omalizumab in patients with severe allergic asthma–a real life study M. Kallieri (Aspropyrgos, Greece)
Moleculer characterization of severe allergic asthma patients via exhaled breath volatile organic compounds(Ege University Translational Pulmonology Research Group [EgeTPRG]) O. Goksel (Izmir, Bornova, Turkey)
Cluster analysis of severe life-threatening asthma: identification of a distinct phenotype characterized by high serum eosinophils P. Lau (Singapore, Singapore)
Migration status as a risk factor for adult-onset asthma R. Aarab (Amsterdam, Netherlands)
Predictors of sputum and BAL eosinophilia in the Wessex Severe Asthma Cohort T. Jones (Portsmouth, United Kingdom)
Multiple breath nitrogen washout test and methacholine challenge test in clinical suspicion of asthma. A. Siebeneichler (PORTO ALEGRE/ RS, Brazil)
IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status? A. Haccuria (Brussels, Belgium)
Weight-adjusted Intravenous Reslizumab Attenuates Airway Eosinophilia in Severe Asthmatics compared to 100 mg Subcutaneous Mepolizumab M. Mukherjee (Hamilton, ON, Canada)